Novavax opens Phase 3 trial for COVID-19 vaccine candidate
Novavax opens Phase 3 trial for COVID-19 vaccine candidate
Another vaccine candidate is taking a step forward.
Novavax announced Monday it is starting a phase three trial for its vaccine candidate in the United States and Mexico.
Tampa will host a site for the clinical trial.